ANSYS - FDA - Avicenna
Roundtable Discussion

SAVE THE DATE! Roundtable discussion in Washington on 11 October 2019

 

For those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?". 

 

The goal of the meeting is to discuss opportunities and challenges when utilizing in silico approaches during development and regulatory review.  The event will be organized around 2 panel discussions, where senior leaders from the largest medical device and pharmaceutical companies will be sharing their experience and expectations.

When and where: 11 October 2019, Marriott at Hyattsville Maryland (same hotel as BMES Conference).

 

Please register here to reserve your spot.

Do not hesitate to contact Krista Loeffler at krista.loeffler@ansys.com for more information.

 

The draft agenda is structured as follows:

Avicenna Alliance news

The European Commission published its Beating Cancer Plan

On 3 February the European Commission published its much-awaited Beating Cancer Plan. The Plan develops proposals and key initiatives for...

find out more ›

Alliance provides feedback on the creation of a European Health Data Space

On 3 February, the Avicenna Alliance has submitted its feedback to the inception impact assessment on the European Health...

find out more ›

European Commission publishes evaluation on Directive on patients' rights in cross-border healthcare

On 15 January, the European Commission published an evaluation and fitness check roadmap on the...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up